Related Experiment Video
Updated: Feb 7, 2026

An Intestinal Gut Organ Culture System for Analyzing Host-Microbiota Interactions
Published on: June 30, 2021
Shaping the Tumor Microenvironment: Insights from Host-Microbiota Interactions.
Khiem C Lam1,2, Romina S Goldszmid1
1Laboratory of Integrative Cancer Immunology (LICI), Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, Maryland.
The gut microbiota influences cancer treatment success by modulating immune responses. Type I interferon is a key mediator in how gut microbes affect immunity and cancer therapy outcomes.
Area of Science:
- Immunology
- Microbiology
- Oncology
Background:
- The gut microbiota plays a crucial role in cancer therapy efficacy.
- Microbiota-mediated immune responses impact both systemic immunity and the tumor microenvironment.
Purpose of the Study:
- To elucidate the mechanistic basis of microbiota-host interactions in cancer therapy.
- To highlight the role of type I interferon in microbiota-driven immune modulation.
Main Methods:
- Review of current scientific literature.
- Analysis of mechanistic insights into immune system modulation by gut microbes.
Main Results:
- Gut microbiota composition significantly impacts cancer treatment outcomes.
- Type I interferon acts as a central mediator in microbiota-induced immune responses.
Conclusions:
- Understanding microbiota-interferon interactions is key to optimizing cancer therapies.
- Targeting the gut microbiota and type I interferon pathways may enhance therapeutic efficacy.
Related Concept Videos
The Tumor Microenvironment
Molecular Shape and Polarity
VSEPR Theory and the Basic Shapes
Molecular Shapes
Two regions of electron density in a diatomic...
First Derivatives and the Shape of a Graph
Second Derivatives and the Shape of a Graph

